ArticleThoracic cancer2026

BAP1 Loss Might Be a Predictive Biomarker for Immunotherapy Response in Pleural Mesothelioma.

Reina Imase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.